Mauna Kea Technologies SA

ALMKT

Company Profile

  • Business description

    Mauna Kea Technologies SA is a medical device company that develops, manufactures and markets an imaging platform for visualizing tissue at the cellular level, in real time, during standard procedures, with the mission of eliminating uncertainties in diagnosis and treatment through direct visualization of tissue in vivo at the microscopic level. The company’s flagship product, Cellvizio, is the smallest microscope, designed for direct use during minimally invasive procedures. It operates in a single business segment: endomicroscopy. Its geographical presence includes EMEA (Europe, Middle East, Africa), USA and Canada, and Asia with the majority of the revenue deriving from USA and Canada.

  • Contact

    9 rue d'Enghien
    Paris75010
    FRA

    T: +33 148240345

    https://www.maunakeatech.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2025

    Employees

    53

Stocks News & Analysis

stocks

2 picks in an undervalued ASX sector

Investors may be too pessimistic about this industry.
stocks

AMD and OpenAI partnership

What does another huge AI deal mean for investors?
stocks

Undervalued ASX founder-led companies

Can this strategy pick the winners?

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,244.8011.80-0.13%
CAC 408,049.2174.360.93%
DAX 4024,605.63219.850.90%
Dow JONES (US)46,665.6462.660.13%
FTSE 1009,542.3358.750.62%
HKSE26,829.46128.31-0.48%
NASDAQ22,941.24152.880.67%
Nikkei 22547,734.99215.89-0.45%
NZX 50 Index13,568.4837.190.27%
S&P 5006,740.9726.380.39%
S&P/ASX 2008,947.6010.80-0.12%
SSE Composite Index3,882.7820.250.52%

Market Movers